About Lucent Diagnostics
Lucent Diagnostics, a commercial brand of Quanterix, was created in 2023 to deliver revolutionary tools that can aid in the earlier detection of cognitive disease. Powered by the ultra-sensitive SimoaTM technology, Lucent Diagnostics bridges the gap between research and clinical use by offering products and services designed specifically to meet the separate needs of institutions and healthcare providers. With more than a decade of proven success within the neurology research space, supported by thousands of publications and partnerships, Quanterix aims to directly impact the landscape of cognitive disease through its commercial brand, Lucent Diagnostics. Headquartered in Billerica, Massachusetts Lucent Diagnostics is comprised of:
- Dedicated leadership team
- On-site, CLIA certified lab with dedicated team
- Medical advisors and provider support team
- National field sales team
- National strategic accounts team
- Dedicated customer service team
Certificates and accreditations
FAQ & Customer Notifications
Click a question below to read the answer.
About LucentAD
Getting the LucentAD Test
Test Change Notifications
Other Questions
Disclaimer
The information provided on this website is for educational purposes only and should not be considered as medical advice. Please consult with your healthcare provider for personalized guidance and treatment options.